Frequently Asked Questions
Factors such as rising ratio of capitals and financing for the advancement of antibiotics and high-level instruments for experimentation as well as diagnosis of the illness are the major growth driving factors.
Thermo Fisher Scientific Inc. (U.S.), Siemens (Germany), Seegene Inc (South Korea), Curetis (Germany), SolGent Co., Ltd (South Korea), Mologic Ltd. (U.K.), Abbott (U.S.), altona Diagnostics GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), BioMaxima SA (Poland), CTK Biotech, Inc (U.S.), VivaChek Biotech (Hangzhou) Co., Ltd. (U.S.), Sensing Self PTE. Ltd (India) and Hangzhou Biotest Biotech Co., LTD. (China) are the major companies operating in this market.
On the basis of technology, the Sputum Test Market is segmented into RT-PCR, IgG, IgM ELISA Test, Microneutralization Assays.
The major countries covered in the Sputum Test Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
